Article
E3 ligase MG53 suppresses tumor growth by degrading cyclin D1
7 Jul 2023
Abstract excerpt
Due to the essential role of cyclin D1 in regulating transition from G1 to S phase in cell cycle, aberrant cyclin D1 expression is a major oncogenic event in many types of cancers. In particular, the dysregulation of ubiquitination-dependent degradation of cyclin D1 contributes to not only the pathogenesis of malignancies but also the refractory to cancer treatment regiments with CDK4/6 inhibitors. Here we show...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
